LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 22

Search options

  1. Article ; Online: Anti-angiogenic activity of rPAI-1(23) and vasa vasorum regression.

    Mulligan-Kehoe, Mary Jo

    Trends in cardiovascular medicine

    2013  Volume 23, Issue 4, Page(s) 114–120

    Abstract: The vasa vasorum are unique networks of vessels that become angiogenic in response to changes in the vessel wall. Structural studies, using various imaging modalities, show that the vasa vasorum form a plexus of microvessels during the atherosclerotic ... ...

    Abstract The vasa vasorum are unique networks of vessels that become angiogenic in response to changes in the vessel wall. Structural studies, using various imaging modalities, show that the vasa vasorum form a plexus of microvessels during the atherosclerotic disease process. The events that stimulate vasa vasorum neovascularization remain unclear. Anti-angiogenic molecules have been shown to inhibit/regress the neovascularization; they provide significant insight into vasa vasorum function, structure, and specific requirements for growth and stability. This review discusses evidence for and against potential stimulators of vasa vasorum neovascularization. Anti-angiogenic rPAI-123, a truncated isoform of plasminogen activator inhibitor-1 (PAI-1) stimulates a novel pathway for regulating plasmin activity. This mechanism contributes significantly to vasa vasorum regression/collapse and is discussed as a model of regression.
    MeSH term(s) Angiogenesis Inhibitors/metabolism ; Animals ; Humans ; Models, Biological ; Neovascularization, Pathologic/metabolism ; Neovascularization, Pathologic/physiopathology ; Plaque, Atherosclerotic/metabolism ; Plaque, Atherosclerotic/physiopathology ; Plasminogen Activator Inhibitor 1/metabolism ; Vasa Vasorum/metabolism ; Vasa Vasorum/physiopathology
    Chemical Substances Angiogenesis Inhibitors ; Plasminogen Activator Inhibitor 1
    Language English
    Publishing date 2013-01-11
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1097434-9
    ISSN 1873-2615 ; 1050-1738
    ISSN (online) 1873-2615
    ISSN 1050-1738
    DOI 10.1016/j.tcm.2012.09.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The vasa vasorum in diseased and nondiseased arteries.

    Mulligan-Kehoe, Mary Jo

    American journal of physiology. Heart and circulatory physiology

    2009  Volume 298, Issue 2, Page(s) H295–305

    Abstract: The vasa vasorum form a network of microvasculature that originate primarily in the adventitial layer of large arteries. These vessels supply oxygen and nutrients to the outer layers of the arterial wall. The expansion of the vasa vasorum to the second ... ...

    Abstract The vasa vasorum form a network of microvasculature that originate primarily in the adventitial layer of large arteries. These vessels supply oxygen and nutrients to the outer layers of the arterial wall. The expansion of the vasa vasorum to the second order is associated with neovascularization related to progression of atherosclerosis. Immunohistological analysis of human plaques from autopsied aortas have defined plaque progression and show a significant correlation with vasa vasorum neovascularization. Recent technological advances in microcomputed tomography have enabled investigation of vasa vasorum structure and function in nondiseased large arteries from pigs and dogs. Smaller mammals, particularly mice with genetic modifications that enable disease development, have been used extensively to study the vasa vasorum in diseased vessels. Despite the fact that most mouse models that are used to study atherosclerosis are unable to develop plaque to the extent found in humans, studies in both humans and mice underscore the importance of angiogenic vasa vasorum in progression of atherosclerosis. Those who have examined the vasa vasorum in occluded vessels of nondiseased pigs and dogs find that inhibition of the vasa vasorum makes the animals atheroprone. Atherosclerosis is a multifactorial disease. There is increasing evidence that factors, produced in response to changes in the arterial wall, collaborate with the vasa vasorum to enhance the disease process.
    MeSH term(s) Animals ; Arteritis/diagnostic imaging ; Arteritis/pathology ; Arteritis/physiopathology ; Atherosclerosis/diagnostic imaging ; Atherosclerosis/pathology ; Atherosclerosis/physiopathology ; Disease Models, Animal ; Disease Progression ; Dogs ; Humans ; Mice ; Neovascularization, Pathologic/diagnostic imaging ; Neovascularization, Pathologic/pathology ; Neovascularization, Pathologic/physiopathology ; Swine ; Tomography, X-Ray Computed ; Vasa Vasorum/diagnostic imaging ; Vasa Vasorum/pathology ; Vasa Vasorum/physiopathology
    Language English
    Publishing date 2009-11-25
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 603838-4
    ISSN 1522-1539 ; 0363-6135
    ISSN (online) 1522-1539
    ISSN 0363-6135
    DOI 10.1152/ajpheart.00884.2009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Vasa vasorum in normal and diseased arteries.

    Mulligan-Kehoe, Mary Jo / Simons, Michael

    Circulation

    2014  Volume 129, Issue 24, Page(s) 2557–2566

    MeSH term(s) Adventitia/blood supply ; Adventitia/physiology ; Adventitia/physiopathology ; Animals ; Arteries/physiology ; Arteries/physiopathology ; Atherosclerosis/physiopathology ; Homeostasis/physiology ; Humans ; Vasa Vasorum/physiology ; Vasa Vasorum/physiopathology ; Veins/physiology ; Veins/physiopathology
    Language English
    Publishing date 2014-06-17
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 80099-5
    ISSN 1524-4539 ; 0009-7322 ; 0069-4193 ; 0065-8499
    ISSN (online) 1524-4539
    ISSN 0009-7322 ; 0069-4193 ; 0065-8499
    DOI 10.1161/CIRCULATIONAHA.113.007189
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Vascular disease in scleroderma: angiogenesis and vascular repair.

    Mulligan-Kehoe, Mary Jo / Simons, Michael

    Rheumatic diseases clinics of North America

    2008  Volume 34, Issue 1, Page(s) 73–9; vi

    Abstract: Vascular abnormalities are one of the primary pathologic components of scleroderma. An early vascular indicator is aberrant nail fold capillaries that appear to undergo a switch from a pro- to anti-angiogenic process. Later in the disease process, ... ...

    Abstract Vascular abnormalities are one of the primary pathologic components of scleroderma. An early vascular indicator is aberrant nail fold capillaries that appear to undergo a switch from a pro- to anti-angiogenic process. Later in the disease process, ineffective and aberrant wound healing becomes apparent with frequent and widespread fibrosis. Pulmonary hypertension, largely due to the loss of pulmonary arterial vasculature, is frequently observed in late stages of the disease. The common theme of all these processes is abnormal regeneration of the vasculature and ongoing vascular losses due to defective maintenance of the vasculature. Although most aspects of vascular injury in scleroderma are poorly understood, certain biologic themes are beginning to emerge that are important in understanding scleroderma-related vascular disease.
    MeSH term(s) Angiogenesis Inhibitors/physiology ; Capillaries/pathology ; Humans ; Neovascularization, Physiologic/physiology ; Scleroderma, Systemic/complications ; Scleroderma, Systemic/physiopathology ; Vascular Diseases/etiology ; Vascular Diseases/physiopathology ; Wound Healing/physiology
    Chemical Substances Angiogenesis Inhibitors
    Language English
    Publishing date 2008-02
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 92118-x
    ISSN 1558-3163 ; 0889-857X
    ISSN (online) 1558-3163
    ISSN 0889-857X
    DOI 10.1016/j.rdc.2007.12.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Advances in imaging angiogenesis and inflammation in atherosclerosis

    Zagorchev, Lyubomir / Mulligan-Kehoe, Mary Jo

    Thrombosis and Haemostasis

    2011  Volume 105, Issue 05, Page(s) 820–827

    Abstract: Advances in imaging technology have provided powerful tools for dissecting the angiogenic and inflammatory aspects of atherosclerosis. Improved technology along with multi-modal approaches has expanded the utilisation of imaging. Recent advances provide ... ...

    Abstract Advances in imaging technology have provided powerful tools for dissecting the angiogenic and inflammatory aspects of atherosclerosis. Improved technology along with multi-modal approaches has expanded the utilisation of imaging. Recent advances provide the ability to better define structure and development of angiogenic vessels, identify relationships between inflammatory mediators and the vessel wall, validate biological effects of anti-inflammatory and anti-angiogenic drugs, delivery and/or targeting specific molecules to inflammatory regions of atherosclerotic plaques.
    Keywords Atherosclerosis ; inflammation ; angiogenesis ; imaging
    Language English
    Publishing date 2011-01-01
    Publisher Schattauer GmbH
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 518294-3
    ISSN 2567-689X ; 0340-6245
    ISSN (online) 2567-689X
    ISSN 0340-6245
    DOI 10.1160/TH10-08-0562
    Database Thieme publisher's database

    More links

    Kategorien

  6. Article: Current concepts in normal and defective angiogenesis: implications for systemic sclerosis.

    Mulligan-Kehoe, Mary Jo / Simons, Michael

    Current rheumatology reports

    2005  Volume 9, Issue 2, Page(s) 173–179

    Abstract: Vascular abnormalities are a major component of systemic sclerosis, but little is known about the events or mechanisms that initiate vascular injury and prevent its repair. Early stages of systemic sclerosis are characterized by an exaggerated angiogenic ...

    Abstract Vascular abnormalities are a major component of systemic sclerosis, but little is known about the events or mechanisms that initiate vascular injury and prevent its repair. Early stages of systemic sclerosis are characterized by an exaggerated angiogenic response later replaced by defective wound healing and fibrosis. In this review, we summarize the current knowledge of the angiogenic imbalance in systemic sclerosis.
    MeSH term(s) Connective Tissue/blood supply ; Connective Tissue/pathology ; Humans ; Neovascularization, Pathologic/physiopathology ; Neovascularization, Physiologic ; Scleroderma, Systemic/complications ; Scleroderma, Systemic/physiopathology ; Wound Healing
    Language English
    Publishing date 2005-06-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2057357-1
    ISSN 1523-3774
    ISSN 1523-3774
    DOI 10.1007/s11926-007-0013-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: The functions of plasminogen activator inhibitor-1: do we have all the pieces of PAI?

    Mulligan-Kehoe, Mary Jo / Schwartz, Gary N / Zacharski, Leo R

    Thrombosis research

    2006  Volume 117, Issue 5, Page(s) 483–486

    MeSH term(s) Binding Sites ; Gene Expression Regulation ; Humans ; Plasminogen Activator Inhibitor 1/genetics ; Plasminogen Activator Inhibitor 1/metabolism ; Plasminogen Activator Inhibitor 1/physiology ; Plasminogen Activators/metabolism ; Vitronectin/metabolism
    Chemical Substances Plasminogen Activator Inhibitor 1 ; SERPINE1 protein, human ; Vitronectin ; Plasminogen Activators (EC 3.4.21.-)
    Language English
    Publishing date 2006
    Publishing country United States
    Document type Editorial
    ZDB-ID 121852-9
    ISSN 1879-2472 ; 0049-3848
    ISSN (online) 1879-2472
    ISSN 0049-3848
    DOI 10.1016/j.thromres.2005.05.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Myeloid Acyl-CoA:Cholesterol Acyltransferase 1 Deficiency Reduces Lesion Macrophage Content and Suppresses Atherosclerosis Progression.

    Huang, Li-Hao / Melton, Elaina M / Li, Haibo / Sohn, Paul / Rogers, Maximillian A / Mulligan-Kehoe, Mary Jo / Fiering, Steven N / Hickey, William F / Chang, Catherine C Y / Chang, Ta-Yuan

    The Journal of biological chemistry

    2016  Volume 291, Issue 12, Page(s) 6232–6244

    Abstract: Acyl-CoA:cholesterol acyltransferase 1 (Acat1) converts cellular cholesterol to cholesteryl esters and is considered a drug target for treating atherosclerosis. However, in mouse models for atherosclerosis, global Acat1 knockout (Acat1(-/-)) did not ... ...

    Abstract Acyl-CoA:cholesterol acyltransferase 1 (Acat1) converts cellular cholesterol to cholesteryl esters and is considered a drug target for treating atherosclerosis. However, in mouse models for atherosclerosis, global Acat1 knockout (Acat1(-/-)) did not prevent lesion development. Acat1(-/-) increased apoptosis within lesions and led to several additional undesirable phenotypes, including hair loss, dry eye, leukocytosis, xanthomatosis, and a reduced life span. To determine the roles of Acat1 in monocytes/macrophages in atherosclerosis, we produced a myeloid-specific Acat1 knockout (Acat1(-M/-M)) mouse and showed that, in the Apoe knockout (Apoe(-/-)) mouse model for atherosclerosis, Acat1(-M/-M) decreased the plaque area and reduced lesion size without causing leukocytosis, dry eye, hair loss, or a reduced life span. Acat1(-M/-M) enhanced xanthomatosis in apoe(-/-) mice, a skin disease that is not associated with diet-induced atherosclerosis in humans. Analyses of atherosclerotic lesions showed that Acat1(-M/-M) reduced macrophage numbers and diminished the cholesterol and cholesteryl ester load without causing detectable apoptotic cell death. Leukocyte migration analysis in vivo showed that Acat1(-M/-M) caused much fewer leukocytes to appear at the activated endothelium. Studies in inflammatory (Ly6C(hi)-positive) monocytes and in cultured macrophages showed that inhibiting ACAT1 by gene knockout or by pharmacological inhibition caused a significant decrease in integrin β 1 (CD29) expression in activated monocytes/macrophages. The sparse presence of lesion macrophages without Acat1 can therefore, in part, be attributed to decreased interaction between inflammatory monocytes/macrophages lacking Acat1 and the activated endothelium. We conclude that targeting ACAT1 in a myeloid cell lineage suppresses atherosclerosis progression while avoiding many of the undesirable side effects caused by global Acat1 inhibition.
    MeSH term(s) Acetyl-CoA C-Acetyltransferase/genetics ; Acetyl-CoA C-Acetyltransferase/metabolism ; Animals ; Apoptosis ; Atherosclerosis/genetics ; Atherosclerosis/immunology ; Atherosclerosis/pathology ; B-Lymphocytes/metabolism ; Bone Marrow/pathology ; Cell Movement ; Cell Proliferation ; Diet, High-Fat/adverse effects ; Disease Progression ; Endothelium, Vascular/immunology ; Endothelium, Vascular/pathology ; Female ; Hematopoietic Stem Cells/physiology ; Leukocytosis/genetics ; Leukocytosis/immunology ; Macrophages/immunology ; Male ; Mice, Inbred C57BL ; Mice, Knockout ; Myeloid Cells/enzymology
    Chemical Substances Acat1 protein, mouse (EC 2.3.1.9) ; Acetyl-CoA C-Acetyltransferase (EC 2.3.1.9)
    Language English
    Publishing date 2016-01-21
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.M116.713818
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Truncated Plasminogen Activator Inhibitor-1 Protein Protects From Pulmonary Fibrosis Mediated by Irradiation in a Murine Model.

    Chung, Eun Joo / McKay-Corkum, Grace / Chung, Su / White, Ayla / Scroggins, Bradley T / Mitchell, James B / Mulligan-Kehoe, Mary Jo / Citrin, Deborah

    International journal of radiation oncology, biology, physics

    2015  Volume 94, Issue 5, Page(s) 1163–1172

    Abstract: Purpose: To determine whether the delivery of recombinant truncated plasminogen activator inhibitor-1 (PAI-1) protein (rPAI-1(23)) would protect from the development of radiation-induced lung injury.: Methods and materials: C57Bl/6 mice received ... ...

    Abstract Purpose: To determine whether the delivery of recombinant truncated plasminogen activator inhibitor-1 (PAI-1) protein (rPAI-1(23)) would protect from the development of radiation-induced lung injury.
    Methods and materials: C57Bl/6 mice received intraperitoneal injections of rPAI-1(23) (5.4 μg/kg/d) or vehicle for 18 weeks, beginning 2 days before irradiation (IR) (5 daily fractions of 6 Gy). Cohorts of mice were followed for survival (n=8 per treatment) and tissue collection (n=3 per treatment and time point). Fibrosis in lung was assessed with Masson-Trichrome staining and measurement of hydroxyproline content. Senescence was assessed with staining for β-galactosidase activity in lung and primary pneumocytes.
    Results: Hydroxyproline content in irradiated lung was significantly reduced in mice that received rPAI-1(23) compared with mice that received vehicle (IR+vehicle: 84.97 μg/lung; IR+rPAI-1(23): 56.2 μg/lung, P=.001). C57Bl/6 mice exposed to IR+vehicle had dense foci of subpleural fibrosis at 19 weeks, whereas the lungs of mice exposed to IR+rPAI-1(23) were largely devoid of fibrotic foci. Cellular senescence was significantly decreased by rPAI-1(23) treatment in primary pneumocyte cultures and in lung at multiple time points after IR.
    Conclusions: These studies identify that rPAI-1(23) is capable of preventing radiation-induced fibrosis in murine lungs. These antifibrotic effects are associated with increased fibrin metabolism, enhanced matrix metalloproteinase-3 expression, and reduced senescence in type 2 pneumocytes. Thus, rPAI-1(23) is a novel therapeutic option for radiation-induced fibrosis.
    MeSH term(s) Alveolar Epithelial Cells/drug effects ; Alveolar Epithelial Cells/metabolism ; Alveolar Epithelial Cells/radiation effects ; Animals ; Cell Proliferation ; Cellular Senescence/drug effects ; Cellular Senescence/radiation effects ; Collagen/metabolism ; Cytokines/metabolism ; Female ; Fibrin/metabolism ; Hydroxyproline/analysis ; Hydroxyproline/metabolism ; Lung/metabolism ; Lung/radiation effects ; Matrix Metalloproteinase 3/metabolism ; Mice ; Mice, Inbred C57BL ; NIH 3T3 Cells ; Plasminogen Activator Inhibitor 1/metabolism ; Plasminogen Activator Inhibitor 1/therapeutic use ; Pulmonary Fibrosis/etiology ; Pulmonary Fibrosis/metabolism ; Pulmonary Fibrosis/prevention & control ; Radiation Pneumonitis/complications ; Radiation Pneumonitis/metabolism ; Real-Time Polymerase Chain Reaction ; Recombinant Proteins/therapeutic use
    Chemical Substances Cytokines ; Plasminogen Activator Inhibitor 1 ; Recombinant Proteins ; SERPINE1 protein, human ; Fibrin (9001-31-4) ; Collagen (9007-34-5) ; Matrix Metalloproteinase 3 (EC 3.4.24.17) ; Hydroxyproline (RMB44WO89X)
    Language English
    Publishing date 2015-12-14
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 197614-x
    ISSN 1879-355X ; 0360-3016
    ISSN (online) 1879-355X
    ISSN 0360-3016
    DOI 10.1016/j.ijrobp.2015.11.044
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Antiangiogenic activity of rPAI-1(23) promotes vasa vasorum regression in hypercholesterolemic mice through a plasmin-dependent mechanism.

    Mollmark, Jessica / Ravi, Saranya / Sun, Baiming / Shipman, Samantha / Buitendijk, Maarten / Simons, Michael / Mulligan-Kehoe, Mary Jo

    Circulation research

    2011  Volume 108, Issue 12, Page(s) 1419–1428

    Abstract: Rationale: The antiangiogenic activity of rPAI-1(23), a truncated plasminogen activator inhibitor-1 (PAI-1) protein, induces vasa vasorum collapse and significantly reduces plaque area and plaque cholesterol in hypercholesterolemic low-density ... ...

    Abstract Rationale: The antiangiogenic activity of rPAI-1(23), a truncated plasminogen activator inhibitor-1 (PAI-1) protein, induces vasa vasorum collapse and significantly reduces plaque area and plaque cholesterol in hypercholesterolemic low-density lipoprotein receptor-deficient/apolipoprotein B48-deficient mice.
    Objective: The objective of this study was to examine rPAI-1(23)-stimulated mechanisms that cause vasa vasorum collapse.
    Methods and results: The rPAI-1(23) protein opposed PAI-1 antiproteolytic function by stimulating a 1.6-fold increase in plasmin activity compared with the saline-treated counterpart. The increased proteolytic activity corresponded to increased activity of matrix metalloproteinase-3 and degradation of fibrin(ogen), nidogen, and perlecan in the adventitia of descending aortas. PAI-1 activity was reduced by 48% in response to rPAI-1(23); however, PAI-1 protein expression levels were similar in the rPAI-1(23)- and saline-treated hypercholesterolemic mice. Coimmunoprecipitation assays demonstrated a novel PAI-1-plasminogen complex in protein from the descending aorta of rPAI-1(23)- and saline-treated mice, but complexed PAI-1 was 1.6-fold greater in rPAI-1(23)-treated mice. Biochemical analyses demonstrated that rPAI-1(23) and PAI-1 binding interactions with plasminogen increased plasmin activity and reduced PAI-1 antiproteolytic activity.
    Conclusions: We conclude that rPAI-1(23) causes regression or collapse of adventitial vasa vasorum in hypercholesterolemic mice by stimulating an increase in plasmin activity. The rPAI-1(23)-enhanced plasmin activity was achieved through a novel mechanism by which rPAI-1(23) and PAI-1 bound plasminogen in a cooperative manner to increase plasmin activity and reduce PAI-1 activity.
    MeSH term(s) Angiogenesis Inhibitors/pharmacology ; Animals ; Fibrinolysin/genetics ; Fibrinolysin/metabolism ; Hypercholesterolemia/genetics ; Hypercholesterolemia/metabolism ; Hypercholesterolemia/pathology ; Mice ; Mice, Knockout ; Plasminogen/genetics ; Plasminogen/metabolism ; Serpin E2/pharmacology ; Vasa Vasorum/metabolism ; Vasa Vasorum/pathology
    Chemical Substances Angiogenesis Inhibitors ; Serpin E2 ; Serpine2 protein, mouse ; Plasminogen (9001-91-6) ; Fibrinolysin (EC 3.4.21.7)
    Language English
    Publishing date 2011-05-05
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 80100-8
    ISSN 1524-4571 ; 0009-7330 ; 0931-6876
    ISSN (online) 1524-4571
    ISSN 0009-7330 ; 0931-6876
    DOI 10.1161/CIRCRESAHA.111.246249
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top